Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
June 2005
Features
Letter to the Editor
The FDA, Vioxx®, and the Repercussions of Direct-to-Consumer Advertising
John A. Frantz, MD
Health Care and Law
Psychologists Gain a Foothold in the Battle for Prescribing Privileges
Dr. Field discusses the trend of states allowing psychologists to prescribe psychotropic medications.
Robert I. Field, JD, MPH, PhD
Book Review
The Language of Life: How Cells Communicate in Health and Disease
Author: Debra Niehoff, PhD
Reviewed by Mark Noble, PhD
Evaluation of Three 5-HT3 Receptor Antagonists in the Prevention of Postoperative Nausea and Vomiting in Adults
The authors compare the efficacy of three antiemetic medications for PONV: ondansetron (Zofran®), granisetron (Kytril®), and dolasetron (Anzemet®).
Shan Wang, PharmD, Joseph Greco, MD, Reena A. Joseph, PharmD Candidate, Martin Feuerman, MS, and Brian Malone, MS
Consensus Panel Recommendations for the Assessment and Management of Breakthrough Pain. Part 2 Management
The authors continue their discussion of pharmacological and nonpharmacological therapies with a focus on criteria for the best agent, the subtypes of breakthrough pain, and the economic and quality-of life considerations.
Daniel Bennett, MD, Allen W. Burton, MD, Scott Fishman, MD,
Barry Fortner, PhD, Bill McCarberg, MD, Chris Miaskowski, PhD, RN,
David Nash, MD, MBA, Marco Pappagallo, MD, Richard Payne, MD, James Ray, PharmD, Eugene R. Viscusi, MD, and Winston Wong, PharmD
Departments
Editorial
Happy Anniversary!
David Nash, MD, MBA, describes the mission and
vision of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR) upon the occasion of its 10th anniversary.
David Nash, MD, MBA
Medication Errors
It Doesn’t Pay to Play the Percentages with Drug Dosages
Matthew Grissinger, RPh, FASCP, discusses some common and dangerous problems associated with the dosing of epinephrine and other drugs used for resuscitating patients.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Pharmacists Try to Reverse CMS Refusal to Fund Second-Year Training for Residents
Stephen Barlas comments on the refusal of the Centers for Medicare & Medicaid Services to fund pharmacy residents in their second year of training.
Stephen Barlas
Drug Forecast
Ezetimibe/Simvastatin (Vytorin®): A Dual Approach to Treating Hyperlipidemia
The authors review the benefits of ezetimibe/simvastatin (Vytorin®) as a therapeutic approach for hyperlipidemia.
Katrina Touchstone, PharmD Candidate, Laura Stark, PharmD Candidate, Marlon Honeywell, PharmD, Marvin Scott, PharmD, and Evans Branch III, PharmD
New Drugs/Drug News/New Medical Devices
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.
